Richard Linder Overview
- Investor Type
Richard Linder General Information
Mr. Richard Linder co-founded and also served as the President, Chief Executive Officer & Chairman of the Medical Advisory Board at CoNextions. He is an Angel Investor. He has twenty-three years of experience as an executive in various facets of the healthcare industry. Most recently, he served as Corporate Vice President for Remedy Informatics and as President of Heart & Vascular, overseeing strategy and positioning in that key vertical market. Mr. Linder began his career in the medical device industry in 1991 with Merit Medical Systems. In 1996, Rich co-founded Rubicon Medical, Inc. and served as President and Chief Executive Officer, taking the company public in 2000 and overseeing its acquisition by Boston Scientific in 2005. Following his tenure at Boston Scientific, where Rich served as Vice President of Vascular Protection, he served as President/CEO and a Director of Coherex Medical from 2006 to 2012. Coherex is a company dedicated to the minimally invasive treatment of structural heart disease. Mr. Linder also serves on the board of directors of Vital Access Corporation, a vascular access company. In addition to his leadership duties, Mr. Linder is very involved in the medical device and biotech community in Utah. Rich is a Co-Founder and Director of BIO-Utah, Utah's life science industry association, and currently serves as Chairman of the Board. He is a member of the University of Utah Biomedical Industrial Advisory Board and was voted a member of the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE). Rich is a member of the Volunteer Leadership Council for the College of Physical and Mathematical Sciences at Brigham Young University. Mr. Linder holds dozens of U.S. and international issued patents and pending patent applications for medical technologies in the areas and disease states coronary artery disease, peripheral vascular disease, neuro-interventional radiology, structural heart disease and heart failure. Mr. Linder attended both Brigham Young University and the University of Utah.
Richard Linder Investments (3)
|Company Name||Deal Date||Deal Type||Deal Size||Industry||Company Stage||Lead Partner|
|Omnisync||16-Mar-2021||Seed Round||000||Financial Software||Generating Revenue||0000000 000000|
|00000 000000||12-Aug-2008||00000 00000||00.00||Surgical Devices||Generating Revenue||0000000 000000|
|0000000000||0000 00000||Other Services (B2C Non-Financial)||Generating Revenue||0000000 000000|
Want detailed data on 3M+ companies?
What you see here scratches the surfaceRequest a free trial
Want to dig into this profile?
We’ll help you find what you needLearn more
Richard Linder Exits (1)
|Company Name||Exit Date||Exit Type||Exit Size|
Richard Linder Investments by Industry, Year, and Region
Richard Linder Team (1)
|Richard Linder||Angel Investor||0|
Richard Linder Co-Investors (8)